CAS 677773-91-0

Methyl3-[(6-amino-2-butoxy-7,8-dihydro-8-oxo-9H-purin-9-yl)methyl]benzeneacetate

CAS : 677773-91-0

Formule : C₁₉H₂₃N₅O₄

Degré de pureté : 98%

Masse moléculaire : 385.4170

Ref: IN-DA01ENLH

Methyl 2-(3-((6-Amino-2-Butoxy-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Phenyl)Acetate

CAS : 677773-91-0

Methyl 2-(3-((6-Amino-2-Butoxy-8-Oxo-7,8-Dihydro-9H-Purin-9-Yl)Methyl)Phenyl)Acetate

Degré de pureté : 98%

Masse moléculaire : 385.42g/mol

Ref: 54-OR1023159

SM-324405

CAS : 677773-91-0

SM-324405

Degré de pureté : ≥95%

Masse moléculaire : 385.42g/mol

Ref: 54-BUP08727

SM-324405

CAS : 677773-91-0

SM-324405 is an agonist of TLR7.

Formule : C₁₉H₂₃N₅O₄

Degré de pureté : 97.83%

Couleur et forme : Solid

Masse moléculaire : 385.42

Ref: TM-T7860

SM 324405

Produit contrôlé

CAS : 677773-91-0

Formule : C₁₉H₂₃N₅O₄

Couleur et forme : Neat

Masse moléculaire : 385.417

Ref: TR-S566030

SM 324405

CAS : 677773-91-0

SM 324405 is a long-acting ligand that has been shown to activate the toll-like receptor (TLR) and induce programmed cell death in cancer cells. SM 324405 has been shown to be an inhibitor of PD-L1 and inhibit the proliferation of tumor cells. It is also used as a treatment method for cancer, through immunotherapy, which increases the patient’s immune response to cancer cells. This drug is being studied for its ability to target specific types of cancers, such as melanoma and lung cancer.

Formule : C₁₉H₂₃N₅O₄

Degré de pureté : Min. 95%

Masse moléculaire : 385.4 g/mol

Ref: 3D-CCB77391